Acipimox
未知生产厂商
Acipimox is a niacin derivative used in Fredrickson type IIb and type IV hyperlipoproteinemia.
Acipimox is a niacin derivative used in Fredrickson type IIb and type IV hyperlipoproteinemia.
Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL.
Used in the treatment of hyperlipidemias (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood).